Carregant...
EXTH-26. PRMT5 AS A DRUGGABLE TARGET FOR GLIOBLASTOMA THERAPY
BACKGROUND: Glioblastoma (GBM) is the most common adult malignant brain tumor. In spite of standard multi modal therapy consisting of surgical resection followed by radiation and concurrent chemotherapy prognosis remains poor. As complexity of tumor heterogeneity is being increasingly recognized as...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692644/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.320 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|